Minocyclin, Doxycyclin, Tetrazyklin Minocyclin Indikation: Schwere Form der Akne. Lyme-Borreliose Kontraindikation: Kinder unter 8 Jahren, Schwangerschaft, Stillzeit. Beipackzettel beachten! Doxycyclin Indikation: Bakterielle Infektionen, Gonorrhoe, Syphilis, Lyme-Borreliose. Infektionen im HNO-Bereich, Pneumonien durch Mykoplasmen, Rickettsien, Chlamydien. Chlamydien- Konjunktivitis und Trachom. Harnwegsinfekte (nur bei nachgewiesener Empfindlichkeit der Erreger), Prostatitis, Gonorrhoe, Syphilis, Cholera, Yersinien und Campylobacter – Infektionen,
Bartonellose, Listeriose, Rickettsiose, Meliodose, Pest, Granuloma inguinale. AmbulanteTherapie
Tropische Sprue. Morbus Whipple. Kontraindikation: Kinder unter 8 Jahren, Schwangerschaft, Stillzeit. Beipackzettel beachten!
Cellerin L, Canfrere I, Ordronneau J, et al. (1994) Acute eosinophilic pneumopathy inducedby minocycline. Rev Pneumol Clin 50(6), 325-8.
Karlsson M, Hammers S, Nilsson-Ehle I, et al. (1996) Concentrations of doxycycline andpenicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis. AntimicrobAgents Chemother 40(5), 1104-7.
Ziska MH, Donta ST, Demarest FC (1996) Physician preferences in the diagnosis andtreatment of Lyme disease in the United States. Infection 24(2), 182-6.
Donta ST (1997) Tetracycline therapy for chronic Lyme disease. Clin Infect Dis S52-6.
Steere AC (1997) Diagnosis and treatment of Lyme arthritis. Med Clin North Am 81(1),179-94.
Horowitz HW, Wormser GP (1998) Doxycycline revisited: an old medicine for emergingdiseases. Arch Intern Med 158(2), 192-3. |
Aberer E, Kehldorfer M, Binder B, et al. (1999) The outcome of Lyme borreliosis in children. Wien Klin Wochenschr 111(22-23), 941-4. |
De Maria A, Primavera A (2000) Possibility of the use of oral long-acting tetracyclines in thetreatment of Lyme neuroborreliosis. Clin Infect Dis 31(3), 848-9. |
Bentas W, Karch H, Huppertz HI (2000) Lyme arthritis in children and adolescents: outcome12 months after initiation of antibiotic therapy. J Rheumatol 27(8), 2025-30.
Dotevall L, Hagberg L (2000) Adverse effects of minocycline versus doxycycline in thetreatment of Lyme neuroborreliosis. Clin Infect Dis 30(2), 410-1. |
Cunha BA (2000) Minocycline versus doxycycline in the treatment of Lyme neuroborreliosis. Clin Infect Dis 30(1), 237-8. |
Donta ST (2001) Treatment of patients with persistent symptoms and a history of Lymedisease. N Engl J Med 345(19), 1424; author reply 1425.
Bernier C, Dréno B (2001) Minocycline. Ann Dermatol Venereol 128(5), 627-37. |Karkkonen K, Stiernstedt SH, Karlsson M (2001) Follow-up of patients treated with oraldoxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33(4), 59-62.
Bell CD, Kovacs K, Horvath E, et al. (2001) Histologic, immunohistochemical, andultrastructural findings in a case of minocycline-associated "black thyroid". Endocr Pathol12(4), 443-51.
Bonnetblanc JM (2002) Doxycycline. Ann Dermatol Venereol 129(6-7), 874-82. |
Stricker RB, Lautin A (2003) The Lyme Wars: time to listen. Expert Opin Investig Drugs12(10), 1609-14.
van Steensel MA (2004) Why minocycline can cause systemic lupus - a hypothesis andsuggestions for therapeutic interventions based on it. Med Hypotheses 63(1), 31-4.
Fritzsche M (2005) Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure withantibiotics attainable? Med Hypotheses 64(3), 438-48.
Ogrinc K, Logar M, Lotric-Furlan S, et al. (2006) Doxycycline versus ceftriaxone for thetreatment of patients with chronic Lyme borreliosis. Wien Klin Wochenschr 118(21-22), 696-701. |
Meer-Scherrer L, Chang Loa C, Adelson ME, et al. (2006) Lyme disease associated withAlzheimer's disease. Curr Microbiol 52(4), 330-2.
Donta ST (2007) Lyme disease guidelines--it's time to move forward. Clin Infect Dis 44(8),1134-5; author reply 1137-9. |
Larkin JM (2008) Lyme disease in children and pregnant women. Med Health R I 91(7), 212.
Wormser GP, Halperin JJ (2008) Oral doxycycline for neuroborreliosis. Lancet Neurol 7(8),665-6.
(2008) Clinical potential of minocycline for schizophrenia. CNS Neurol DisordDrug Targets. 7(4), 376-81.
Ljøstad U, Skogvoll E, Eikeland R, et al. (2008) Oral doxycycline versus intravenousceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind,randomised trial. Lancet Neurol 7(8), 690-5. |
Aupee O, Almeras D, Le Garlantezec P, et al. (2009) Doxycycline. Med Trop (Mars) 69(6),556-8. |
Bernardino AL, Kaushal D, Philipp MT (2009) The antibiotics doxycycline and minocyclineinhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. JInfect Dis 199(9), 1379-88.
Schröder J, Kirch W (2009) Lyme borreliosis: How should erythema migrans be treated inpregnant women?. Dtsch Med Wochenschr 134(46), 2354. |
Gulati RK (2010) Doxycycline in children?--the unanswered question. Pediatr Dermatol27(4), 419. Full Citation
Katsunori T, Iwasaki H, Ikegaya S, Ueda T (2012) Minocycline modulates cytokine andchemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibitingIkB kinase a/b phosphorylation. Translational Research -, 1–11
Unbound MEDLINE results for: Minocyclin and Borreliosis, human Refine this search 1 journal articles in the PubMed database Unbound MEDLINE results for: Minocyclin and tetracyclines, human Refine this search 27 journal articles in the PubMed database Unbound MEDLINE results for: tetracyclines and borreliosis, human Refine this search
Bernt - Dieter Huismans, 2012. Letzte Revision August 2013, www.Huismans.de.vu, www.Huismans.de.nu
Indígenas do Rio Grande do Norte: uma longa história deDurante parte dos séculos XVII e XVIII aconteceu no RN, uma das maioresresistências indígenas do país que recebeu o nome de “Guerra dos Bárbaros”, ou Guerra doAçu, por ter sido o seu epicentro a região do Açu e que depois se expandiu por váriosestados do nordeste. Por mais de quarenta anos, diversas lideranças indígenas lu
20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) Home - 11.04.2010 - Emerging influenza virus: H1N1v and H5N1 Emerging influenza virus: H1N1v and H5N1 Sunday, April 11, 2010, 13:30 - 14:30 Antibodies to interferon-gamma in ultra-low doses: a new option for pandemic influenza S. Tarasov*, V. Zarubaev, J. Tafani, J. Dugina, S. Sergeeva, O. Epstein (M